|Day Low/High||35.77 / 36.09|
|52 Wk Low/High||31.67 / 39.43|
Following up on President Trump's drug pricing speech last week, the FDA posted a list of 39 name-brand drug firms that are allegedly making life tough on generic drug companies.
Why study charts? Because they're like footprints at the scene of the crime, clues to what the big money managers are likely thinking, Jim Cramer says.
These three "strong buy" biotech stocks are primed for outsized growth in the next 12 months. Here's why.
President Trump reduced tensions in Korea, raised them in the Middle East, and mainly relieved them for investors in the drug and healthcare industries.
President Trump delivered a highly-anticipated speech on lowering the cost of drugs for Americans on Friday afternoon.
The EpiPen maker saw a 19% drop in North America net sales due in part to lower sales of branded products.
The most recent short interest data has been released for the 04/13/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Dow Jones Industrial Average by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
A study of analyst recommendations at the major brokerages shows that Pfizer Inc is the #15 broker pick, on average, out of the 30 stocks making up the Dow Jones Industrial Average, according to ETF Channel. Within the broader S&P 500, when components were ranked in terms of analyst favorites, PFE claims the #235 spot.
Stocks were mixed on Tuesday with investors adopting a cautious stance as the Federal Reserve begins a two-day meeting.
U.S. stock futures are mixed as the Federal Reserve kicks off a two-day meeting and Apple is scheduled to report quarterly results.
Global stocks bumped higher Tuesday, while oil prices held at three-and-a-half year highs, amid several key market closures and ahead of what could be a crucial quarterly earnings update from Apple after the close of trading.
I think it very possible that there will be a positive reaction tonight, more likely based on what Tim Cook says.
The drugmakers and health insurer are preparing to unveil first-quarter numbers.
Procter & Gamble, which is buying the Merck unit, was previously reported to be in talks to acquire Pfizer's consumer healthcare business.
Two weeks ago, the agency told Alkermes it needed more trials for antidepressant drug candidate ALKS-5461. The agency, however, had a change of heart, sending shares jumping on the news.
The Trump Administration cut corporate taxes and U.S. Senator Cory Booker hoped pharma companies would cut drug prices. That didn't happen and Booker's new analysis hammers those drug companies.
As President Trump tees up a set of 25% tariffs on a wide range of products against China trade, generic drug makers as well as their patients likely will be affected.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.